Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
Los Angeles, United States
Countries of investment
  • Switzerland
Investment stages
  • Pre-Seed
  • Seed
Industries
    About
    KdT Ventures, founded in 2017 by Cain McClary, is a venture Capital firm focused on early stage frontier science investing. The firm believes in the potential of reprogramming chemistry and biology to solve major global challenges. Their investment philosophy is to support groundbreaking scientific and technological advancements, particularly in BioTech, health tech, and robotics. KdT Ventures often leads the earliest investment rounds and seeks to have a significant impact on budding ventures. Some notable investments include companies like STRM.BIO, Solugen, and PathAI.
    Min check size
    $100K
    Max check size
    $3M
    Fund size
    NPS

    Investment Thesis

    KdT Ventures believes in harnessing nature's code through chemistry and biology to solve some of the greatest challenges. They focus on reprogramming chemistry and biology using creative Technology platforms.
    Lead investor
    Co Invest
    Number of exits
    Preferred contact method

    KdT Ventures Contacts Information

    Primary contact

    Secondary contact

    Portfolio

    Perciv AI

    allO

    Feather

    Avalor AI

    Sibill

    Qneiform

    Send AI

    Vesper

    Crisp

    Plan A

    Bits of Stock

    Farewill

    Teamleader

    Impraise

    DreamQuark

    Fund number
    Vintage Year
    Net Internal Rate of Return
    Investment Multiple
    Capital Allocation
    Management Fee
    Carried Interest
    AUM
    Follow-on Investments
    Graduation Rate
    Write-Off Ratio
    Last profile update timestamp